Genotypic interaction and gender specificity of common genetic variants in the p53/mdm2 network in Crohn's disease

Digestion

Volumn 81, Issue 4, 2010, Pages 246-251

  Zimmer, V ^a   Widmann, T ^b   Muller M ^b   Ong, M F ^b   Stein, J M ^c   Pfreundschuh, M ^b   Lammert, F ^a   Roemer, K ^b   Assmann, G ^b  

^a Department of Medicine II ^*  (Germany)

^b SAARLAND UNIVERSITY   (Germany)

^c UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Apoptosis; Crohn's disease; Epistasis; Genetics; Mdm2; P53; Single nucleotide polymorphism

Indexed keywords

PROTEIN MDM2; PROTEIN P53;

ADULT; APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CONTROLLED STUDY; CROHN DISEASE; FEMALE; GENDER; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ALLELES; APOPTOSIS; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; CROHN DISEASE; FEMALE; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-MDM2; REFERENCE VALUES; RISK ASSESSMENT; SEX FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 75149187002     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000241413     Document Type: Article

References (23)

1. Baumgart DC, Carding SR: Inflammatory bowel disease: cause and immunobiology. Lancet 2007; 369: 1627-1640. (Pubitemid 46722636)
2. Podolsky DK: Inflammatory bowel disease. N Engl J Med 2002; 347: 417-429. (Pubitemid 34851835)
3. Cho JH: The genetics and immunopathogenesis of inflammatory bowel disease. Nat Rev Immunol 2008; 8: 458-466. (Pubitemid 351733422)
4. Boirivant M, Marini M, Di Felice G, Pronio AM, Montesani C, Tersigni R, Strober W: Lamina propria T cells in Crohn's disease and other gastrointestinal inflammation show defective CD2 pathway-induced apoptosis. Gastroenterology 1999; 116: 557-565. (Pubitemid 29106763)
5. Ina K, Itoh J, Fukushima K, Kusugami K, et al: Resistance of Crohn's disease T cells to multiple apoptotic signals is associated with a Bcl-2/Bax mucosal imbalance. J Immunol 1999; 163: 1081-1090. (Pubitemid 29328123)
6. Itoh J, de La Motte C, Strong SA, Levine AD, Fiocchi C: Decreased Bax expression by mucosal T cells favours resistance to apoptosis in Crohn's disease. Gut 2001; 49: 35-41. (Pubitemid 32601877)
7. Sturm A, Itoh J, Jacobberger JW, Fiocchi C: p53 negatively regulates intestinal immunity by delaying mucosal T cell cycling. J Clin Invest 2002; 109: 1481-1492. (Pubitemid 34596174)
8. Sturm A, Leite AZ, Danese S, Krivacic KA, West GA, Mohr S, Jacobberger JW, Fiocchi C: Divergent cell cycle kinetics underlie the distinct functional capacity of mucosal T cells in Crohn's disease and ulcerative colitis. Gut 2004; 53: 1624-1631. (Pubitemid 39434106)
9. Vogelstein B, Lane D, Levine AJ: Surfing the p53 network. Nature 2000; 408: 307-310.
10. Bond GL, Hu W, Bond EE, Robins H, Lutzker SG, Arva NC, Bargonetti J, Bartel F, Taubert H, Wuerl P, Onel K, Yip L, Hwang SJ, Strong LC, Lozano G, Levine AJ: A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans. Cell 2004; 119: 591-602. (Pubitemid 39535748)
11. Dumont P, Leu JI, Della Pietra AC, George DL, Murphy M: The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet 2003; 33: 357-365. (Pubitemid 36278852)
12. Stange EF, Travis SP, Lémann M, et al: European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. Gut 2006; 55:i1-i15. (Pubitemid 43268291)
13. Assmann G, Wieczorek S, Wibisono D, Roemer K, Arning L, Voswinkel J: The p53 G72C and MDM2 T309G single nucleotide polymorphisms in patients with Wegener's granulomatosis. Clin Exp Rheumatol 2008; 26: S72-S75.
14. Hugot JP, Chamaillard M, Zouali H, et al: Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001; 411: 599-603. (Pubitemid 32531408)
15. Ogura Y, Bonen DK, Inohara N, et al: A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001; 411: 603-606. (Pubitemid 32531409)
16. Hampe J, Franke A, Rosenstiel P, et al: A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet 2007; 39: 207-211. (Pubitemid 46184351)
17. Duerr RH, Taylor KD, Brant SR, et al: A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 2006; 314: 1461-1463. (Pubitemid 44871953)
18. Barrett JC, Hansoul S, Nicolae DL, et al: Genome- wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet 2008; 40: 955-962.
19. Bond GL, Levine AJ: A single nucleotide polymorphism in the p53 pathway interacts with gender, environmental stresses and tumor genetics to influence cancer in humans. Oncogene 2007; 26: 1317-1323.
20. Mittelstrass K, Sauter W, Rosenberger A, et al: Early onset lung cancer, cigarette smoking and the SNP309 of the murine double minute-2 (MDM2) gene. BMC Cancer 2008; 8: 113. (Pubitemid 351689705)
21. Bohuslav J, Chen LF, Kwon H, Mu Y, Greene WC: p53 induces NF-kappaB activation by an IkappaB kinase-independent mechanism involving phosphorylation of p65 by ribosomal S6 kinase 1. J Biol Chem 2004; 279: 26115-26125. (Pubitemid 38798756)
22. Komarova EA, Krivokrysenko V, Wang K, et al: p53 is a suppressor of inflammatory response in mice. FASEB J 2005; 19: 1030-1032. (Pubitemid 40827741)
23. Gudkov AV, Komarova EA: Dangerous habits of a security guard: the two faces of p53 as a drug target. Hum Mol Genet 2007; 16:R67-R72.